Similar in size, shape and thickness to a postage stamp, PharmFilm is a truly unique drug delivery platform that represents a leap forward in how pharmaceutical products are developed and administered. PharmFilm benefits both patient and pharmaceutical provider by fostering a more convenient, precise and potentially safer means for delivering prescription drugs.

MonoSol Rx and PharmFilm Drug Delivery Technology

Latest News
Feb 09 2015
MonoSol Rx Leadership Presented PharmFilm Buccal Delivery Clinical Update at Leading Pharmaceutical Technology Meeting
Dec 17 2014
MonoSol Rx names A. Mark Schobel Chief Innovation & Technology Officer; Keith Kendall assumes role of CEO
Oct 06 2014
US Patent Office Institutes Inter Partes Review Brought by MonoSol Rx Against All Claims in Key BDSI BEMA Patent
PharmFilm Advantages

MonoSol Rx has cemented a leadership position in the transition of prescription drugs to film. Our patented PharmFilm® technology platform enables a wide range of pharmaceutical products to be delivered buccally, sublingually, enterally and through other mucosal surfaces for the improvement of healthcare for patients.

Partners and Licensing
Partnering with MonoSol Rx offers pharmaceutical companies the ability to introduce products that are highly differentiated from other dosage forms, both in performance and marketability, creating fresh, dynamic revenue-generating opportunities.